Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril for Prevention of Atrial Fibrillation After Atrial Flutter Ablation
NCT00736294Phase 3Terminated
- Sponsor
- CHU Saint-Etienne
- Start
- Jul 2008
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramipril in Atrial fibrillation (AFib), sponsored by CHU Saint-Etienne. Started Jul 2008; status: terminated.
02
Drugs
ramipril
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00736294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00736294.